Biliary excretion of taurocholate, organic anions and vinblastine in rats with α-naphthylisothiocyanate-induced cholestasis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 7, 2005, Pages 1069-1074

  Kurihara, Hiroko ^a   Sano, Naoyo ^a   Takikawa, Hajime ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bile acid; Cholestasis; Multidrug resistance protein 2; Organic anion; naphthylisothiocyanate

Indexed keywords

1 NAPHTHYL ISOTHIOCYANATE; ANION; BILE SALT; LEUKOTRIENE C4; MULTIDRUG RESISTANCE PROTEIN 2; PRAVASTATIN; TAUROCHOLIC ACID; VINBLASTINE;

ANIMAL EXPERIMENT; ARTICLE; BILE ACID BLOOD LEVEL; BILE DUCT; BILIARY EXCRETION; CANNULATION; CHOLESTASIS; CONTROLLED STUDY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; LIVER CELL MEMBRANE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

EID: 21844440063     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.03794.x     Document Type: Article

References (29)

1. +/bile acid cotransporter. J. Clin. Invest. 1994; 93: 1326-31.
2. +-independent organic anion transporter. Proc. Natl. Acad. Sci. USA 1994; 91: 133-7.
3. Gerloff T, Stieger B, Hagenbuch B et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J. Biol. Chem. 1998; 273: 10 046-50.
4. Paulusma CC, Bosma PJ, Zaman GJ et al. Congenital jaundice rats with a mutation in a multidrug resistance-associated protein gene. Science 1996; 271: 1126-8.
5. Kamimoto Y, Gatmaitan Z, Hsu J, Arias IM. The function of Gp170, the multidrug resistance gene product, in rat liver canalicular membrane vesicles. J. Biol. Chem. 1989; 264: 11 693-8.
6. Vos TA, Hooiveld GJ, Koning H et al. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 1998; 28: 1637-44.
7. Trauner M, Arrese M, Soroka CJ et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997; 113: 255-64.
8. Kubitz R, Wettstein M, Warskulat U, Haussinger D. Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. Gastroenterology 1999; 116: 401-10.
9. Lee JM, Trauner M, Soroka CJ, Stieger B, Meier PJ, Boyer JL. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology 2000; 118: 163-72.
10. Goldfarb S, Singer EJ, Popper H. Experimental cholangitis due to alpha-naphthylisothiocyanate (ANIT). Am. J. Pathol. 1962; 40: 685-95.
11. Schaffner F, Scharnbeck HH, Hutterer F, Denk H, Grim NA, Popper H. Mechanism of cholestasis. VII. α-Naphthylisothiocyanate-induced jaundice. Lab. Invest. 1973; 28: 321-31.
12. Krell H, Hoke H, Pfaff E. Development of intrahepatic cholestasis by α-naphthylisothiocyanate in rats. Gastroenterology 1982; 82: 507-14.
13. Roth RA, Dahm LJ. Neutrophil- and glutathione-mediated hepatotoxicity of α-naphthylisothiocyanate. Drug Metab, Rev. 1997; 29: 153-65.
14. Dietrich CG, Ottenhoff R, de Waart DR, Oude Elferink RP. Role of MRP2 and GSH in intrahepatic cycling of toxins. Toxicology 2001; 167: 73-81.
15. 4 and structurally related conjugates. J. Biol. Chem. 1994; 269: 27 807-10.
16. 4 in the rat. Prostaglandins 1997; 54: 745-55.
17. Fukumura S, Takikawa H, Yamanaka M. Effects of organic anions and bile acid conjugates on biliary excretion of pravastatin in the rat. Pharm. Res. 1998; 15: 72-6.
18. Sato A, Takikawa H, Yamanaka M. Effects of organic anions and vinblastine on biliary excretion of erythromycin in rats. Pharmacology 1999; 59: 249-53.
19. Takikawa H, Sano N, Narita T et al. Biliary excretion of bile acid conjugates in a hyperbilirubinemic mutant Sprague-Dawley rat. Hepatology 1991; 14: 352-60.
20. Takikawa H, Wako Y, Sano N, Yamanaka M. Changes in biliary excretory mechanism in the bile duct-ligated rat. Dig. Dis. Sci. 1996; 41: 256-62.
21. Suzuki C, Sano N, Takikawa H. Effect of dexamethasone on biliary excretion of bile acids and organic anions in rats. Hepatol. Res. 2003; 25: 48-54.
22. Palmer RH. The enzymatic assay of bile acids and related 3α-hydroxysterid: its application to serum and other biological fluids. Methods Enzymol. 1969; 15: 280-88.
23. Hojo M, Sano N, Takikawa H. Effects of lipopolysaccharide on the biliary excretion of bile acids and organic anions in rats. J. Gastroenterol. Hepatol. 2003; 18: 815-21.
24. Marumo T, Fukusato T, Takikawa H. Biliary excretion of bile acids and organic anions in rats with dichloroethylene-induced bile canalicular injury. J. Gastroenterol. 2004; 39: 981-7.
25. Enderle GJ, Delabar U, Krell H. Different pathomechanisms of altered biliary leukotriene C4 elimination in isolated perfused rat liver. Biochem. Pharmacol. 1995; 49: 297-304.
26. Ogawa K, Suzuki H, Hirohashi T et al. Characterization of inducible nature of MRP3 in rat liver. Am. J. Physiol. Gastrointest. Liver Physiol. 2000; 278: G438-46.
27. Schrenk D, Gant TW, Preisegger K-H, Silverman JA, Marino PA, Thorgeirsson AS. Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates. Hepatology 1993; 17: 854-60.
28. Kojima H, Nies AT, Konig J et al. Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis. J. Hepatol. 2003; 39: 693-702.
29. Sakisaka S, Kawaguchi T, Taniguchi E et al. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 2001; 33: 1460-68.